TCG again backs Surrozen in $50M series B

Regenerative medicine company Surrozen raised a $50 Million series B round to move its optimized Wnt signaling mimetics into IND-enabling studies for

Read the full 227 word article

How to gain access

Continue reading with a
two-week free trial.